Add time:09/29/2019 Source:sciencedirect.com
ObjectiveMedication-related osteonecrosis of the jaw (MRONJ) is a pathologic process resulting in progressive jawbone destruction. There are no established guidelines for the medical management of MRONJ. Interest in pentoxifylline and Tocopherol (cas 1406-18-4) is growing as they have been shown to be effective in treating osteoradionecrosis of the jaw. This review evaluates the clinical usefulness of pentoxifylline and tocopherol in treating MRONJ.
We also recommend Trading Suppliers and Manufacturers of Tocopherol (cas 1406-18-4). Pls Click Website Link as below: cas 1406-18-4 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View